Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review
Year: 2016
Type: review
Abstract: Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease which represents a wide spectrum of hepatic damage. Several studies have reported that NAFLD is a strong independent risk factor for coronary artery disease (CAD). And patients with NAFLD are at higher risk and suggested undergoperiodic cardiovascular risk assessment. Cardiovascular disease (CVD) is responsible for the main cause of death in patients with NAFLD, and is mostly influenced by genetic factors. Both NAFLD and CAD are heterogeneous disease. Common pathways involved in the pathogenesis of NAFLD and CAD includes insulin resistance (IR), atherogenic dyslipidemia, subclinical inflammation, oxidative stress, etc. Genomic characteristics of these two diseases have been widely studied, further research about the association of these two diseases draws attention. The gene polymorphisms of adiponectin-encoding gene (ADIPOQ), leptin receptor (LEPR), apolipoprotein C3 (APOC3), peroxisome proliferator-activated receptors (PPAR), sterol regulatory elementbinding proteins (SREBP), transmembrane 6 superfamily member 2 (TM6SF2), microsomal triglyceride transfer protein (MTTP), tumor necrosis factors-alpha (TNF-α) and manganese superoxide dismutase (MnSOD) have been reported to be related to NAFLD and CAD. In this review, we aimed to provide an overview of recent insights into the genetic basis of NAFLD and CAD.
Source: Lipids in Health and Disease
Institutions: Dalian Medical University, Qingdao Municipal Hospital
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: non-alcoholic fatty liver disease, coronary artery disease, genetic polymorphism, genetic susceptibility, insulin resistance, atherogenic dyslipidemia, oxidative stress, adiponectin, leptin receptor, apolipoprotein C-III, peroxisome proliferator-activated receptors, SREBP, TM6SF2, microsomal triglyceride transfer protein, TNF-α, manganese superoxide dismutase, cardiovascular risk
Open Access status: gold
Estimated APC paid: $2,990
OpenAlex ID: W2296700616
